Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04147910 · ClinicalTrials.gov registry record · Phase 1
Phase 1, Open-label Study of the Absorption, Metabolism, and Excretion of [14C]-KW-6356
A Phase 1 study of Healthy Male Subjects, sponsored by Kyowa Kirin.
- Completed
- Registry status
- Phase 1
- Development phase
- 8
- Enrollment target
- 1
- Study location
NCT04147910: Completed Phase 1 study of Healthy Male Subjects, sponsored by Kyowa Kirin.
NCT04147910 is a Phase 1 study of Healthy Male Subjects that has completed, run by Kyowa Kirin. The registered enrollment target is 8 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04147910, a Phase 1 study of Healthy Male Subjects, has completed, sponsored by Kyowa Kirin.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an open-label, single-dose study in healthy male subjects to investigate the absorption, metabolism, and excretion (AME) of KW-6356.
Conditions Studied
Interventions
- DRUG KW-6356
Study Locations (1)
Wisconsin
- Covance Clinical Research Unit Inc. - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2019-08-21 |
| Est. Completion | 2019-10-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04147910
The ClinicalTrials.gov registry entry for NCT04147910 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (87% lower). The listed sponsor is Kyowa Kirin, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Healthy Male Subjects appearing as the primary indexed condition, and to 1 intervention - of which KW-6356 is the first listed.
NCT04147910 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT04147910 about?
NCT04147910 is a clinical study titled "Phase 1, Open-label Study of the Absorption, Metabolism, and Excretion of [14C]-KW-6356". This is an open-label, single-dose study in healthy male subjects to investigate the absorption, metabolism, and excretion (AME) of KW-6356.
What is the current status of trial NCT04147910?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 8 participants. The study started on 2019-08-21. Estimated completion is 2019-10-02.
What conditions does trial NCT04147910 study?
This clinical trial studies the following conditions: Healthy Male Subjects.
What interventions are being tested in trial NCT04147910?
The interventions under investigation include: KW-6356 (DRUG).
Who is sponsoring clinical trial NCT04147910?
This trial is sponsored by Kyowa Kirin, which has 34 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04147910 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.